Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-278722
Filing Date
2018-09-20
Accepted
2018-09-20 16:06:58
Documents
5
Period of Report
2018-10-18
Effectiveness Date
2018-09-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d600447ddef14a.htm DEF 14A 341459
2 GRAPHIC g600447dsp1a.jpg GRAPHIC 6720
3 GRAPHIC g600447dsp1c.jpg GRAPHIC 7347
4 GRAPHIC g600447dsp2a.jpg GRAPHIC 4392
5 GRAPHIC g600447snap1.jpg GRAPHIC 2735
  Complete submission text file 0001193125-18-278722.txt   372457
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 181079503
SIC: 2835 In Vitro & In Vivo Diagnostic Substances